Rozanolixizumab (Rystiggo) for myasthenia gravis

Med Lett Drugs Ther. 2024 Feb 19;66(1696):29-31. doi: 10.58347/tml.2024.1696c.
No abstract available

Keywords: Rystiggo; Vyvgart; Zilbrysq; adverse effects; dosage; drug interactions; efficacy; efgartigimod alfa; lactation; pregnancy; ravulizumab; rituximab; rozanolixizumab; safety; zilucoplan.

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Humans
  • Myasthenia Gravis* / diagnosis
  • Myasthenia Gravis* / drug therapy

Substances

  • rozanolixizumab
  • Antibodies, Monoclonal, Humanized